TCOV
Trust Company of Vermont’s Esperion Therapeutics ESPR Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $295 | Hold |
300
| – | – | ﹤0.01% | 1055 |
|
2025
Q1 | $432 | Hold |
300
| – | – | ﹤0.01% | 994 |
|
2024
Q4 | $660 | Hold |
300
| – | – | ﹤0.01% | 1005 |
|
2024
Q3 | $495 | Hold |
300
| – | – | ﹤0.01% | 1003 |
|
2024
Q2 | $666 | Hold |
300
| – | – | ﹤0.01% | 848 |
|
2024
Q1 | $804 | Buy |
+300
| New | +$804 | ﹤0.01% | 808 |
|
2023
Q4 | – | Sell |
-300
| Closed | -$294 | – | 829 |
|
2023
Q3 | $294 | Hold |
300
| – | – | ﹤0.01% | 787 |
|
2023
Q2 | $417 | Hold |
300
| – | – | ﹤0.01% | 798 |
|
2023
Q1 | $477 | Hold |
300
| – | – | ﹤0.01% | 843 |
|
2022
Q4 | $1.87K | Hold |
300
| – | – | ﹤0.01% | 814 |
|
2022
Q3 | $2K | Hold |
300
| – | – | ﹤0.01% | 919 |
|
2022
Q2 | $2K | Buy |
+300
| New | +$2K | ﹤0.01% | 857 |
|
2022
Q1 | – | Sell |
-300
| Closed | -$2K | – | 442 |
|
2021
Q4 | $2K | Buy |
+300
| New | +$2K | ﹤0.01% | 770 |
|
2021
Q3 | – | Sell |
-300
| Closed | -$6K | – | 432 |
|
2021
Q2 | $6K | Hold |
300
| – | – | ﹤0.01% | 678 |
|
2021
Q1 | $8K | Hold |
300
| – | – | ﹤0.01% | 649 |
|
2020
Q4 | $8K | Hold |
300
| – | – | ﹤0.01% | 650 |
|
2020
Q3 | $11K | Hold |
300
| – | – | ﹤0.01% | 596 |
|
2020
Q2 | $15K | Hold |
300
| – | – | ﹤0.01% | 568 |
|
2020
Q1 | $9K | Hold |
300
| – | – | ﹤0.01% | 669 |
|
2019
Q4 | $18K | Hold |
300
| – | – | ﹤0.01% | 622 |
|
2019
Q3 | $11K | Hold |
300
| – | – | ﹤0.01% | 730 |
|
2019
Q2 | $14K | Hold |
300
| – | – | ﹤0.01% | 690 |
|
2019
Q1 | $12K | Hold |
300
| – | – | ﹤0.01% | 687 |
|
2018
Q4 | $14K | Hold |
300
| – | – | ﹤0.01% | 676 |
|
2018
Q3 | $13K | Hold |
300
| – | – | ﹤0.01% | 760 |
|
2018
Q2 | $12K | Hold |
300
| – | – | ﹤0.01% | 793 |
|
2018
Q1 | $22K | Hold |
300
| – | – | ﹤0.01% | 634 |
|
2017
Q4 | $20K | Hold |
300
| – | – | ﹤0.01% | 666 |
|
2017
Q3 | $15K | Hold |
300
| – | – | ﹤0.01% | 677 |
|
2017
Q2 | $14K | Hold |
300
| – | – | ﹤0.01% | 690 |
|
2017
Q1 | $11K | Hold |
300
| – | – | ﹤0.01% | 693 |
|
2016
Q4 | $4K | Hold |
300
| – | – | ﹤0.01% | 792 |
|
2016
Q3 | $4K | Hold |
300
| – | – | ﹤0.01% | 749 |
|
2016
Q2 | $3K | Hold |
300
| – | – | ﹤0.01% | 775 |
|
2016
Q1 | $5K | Hold |
300
| – | – | ﹤0.01% | 650 |
|
2015
Q4 | $7K | Buy |
300
+150
| +100% | +$3.5K | ﹤0.01% | 655 |
|
2015
Q3 | $4K | Buy |
150
+50
| +50% | +$1.33K | ﹤0.01% | 715 |
|
2015
Q2 | $8K | Buy |
+100
| New | +$8K | ﹤0.01% | 674 |
|